FDA Drug recall D-0121-2016
SERMORELIN/GHRP-6/GHRP-2, Injectable Solution, 9/5.4/5.4MG/9ML, 9mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 15…
- FDA Drug
- Class II
- terminated
- Published 2015-11-04
On 2015-11-04 the FDA classified a Class II recall of SERMORELIN/GHRP-6/GHRP-2, Injectable Solution, 9/5.4/5.4MG/9ML, 9mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 15… by Jd And Sn, citing lack of Assurance of Sterility; all sterile human compounded drugs within expiry.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0121-2016 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2015-07-24 |
| Published | 2015-11-04 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Jd And Sn |
| Distribution | US |
Product
SERMORELIN/GHRP-6/GHRP-2, Injectable Solution, 9/5.4/5.4MG/9ML, 9mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
Reason
Lack of Assurance of Sterility; all sterile human compounded drugs within expiry
Identifiers
| code_info | t10062014@19, t09152014@13, t08262014@1, t08072014@20, t05282015@28, t03062015@14, t02162015@26, 12222014@3, 11262014@6…t10062014@19, t09152014@13, t08262014@1, t08072014@20, t05282015@28, t03062015@14, t02162015@26, 12222014@3, 11262014@6, 11172014@4, 11052014@3, 10272014@7, 10222014@23, 10202014@20, 10152014@5, 10012014@17, 09102014@3, 08182014@9, 07222014@31, 06292015@10, 06232014@3, 06222015@6, 05132015@7, 05062015@7, 05042015@4, 04272015@8, 04222015@6, 03302015@11, 03252015@9, 02202015@24, 01232015@20, 01192015@1, 01052015@8. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0121-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.